Sunrise Medical Research, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Lauderdale Lakes FL United States (1999)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2012
NCT01728753
First Marketed Drug
2011
naproxen (naprosyn)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sunrise Children's Clinic | Sunrise Medical Research, Lauderdale Lakes, FL 33319 | SUNRISE PHARM INC

Active Ingredients

Marketed Drugs (3)

chlordiazepoxide (librium) (2020)

clidinium (quarzan) (2020)

naproxen (naprosyn) (2011)

Drugs in Phase 3 Trials (3)

estradiol (progynon depot) (1 trial)

estrogen (1 trial)

live attenuated influenza virus vaccine (Flumist) (1 trial)

Drugs in Phase 2 Trials (1)

favipiravir (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophic Vaginitis (Phase 3)

Atrophy (Phase 3)

Influenza, Human (Phase 2)

Vaginitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4